Hypoxia-related molecules HIF-1α, CA9, and osteopontin

Basal HIF-1α expression levels are not predictive for radiosensitivity of human cancer cell lines

(2012) D. Schilling et al.   STRAHLENTHERAPIE UND ONKOLOGIE

Overexpression of osteopontin induces angiogenesis of endothelial progenitor cells via the avβ3/PI3K/AKT/eNOS/NO signaling pathway in glioma cells

(2011) Yingyi Wang et al.   EUROPEAN JOURNAL OF CELL BIOLOGY

Small interfering RNA targeting HIF-1α reduces hypoxia-dependent transcription and radiosensitizes hypoxic HT 1080 human fibrosarcoma cells in vitro

(2011) Adrian Staab et al.   STRAHLENTHERAPIE UND ONKOLOGIE

Prognostic impact of hemoglobin level and other factors in patients with high-grade gliomas treated with postoperative radiochemotherapy and sequential chemotherapy based on temozolomide

(2011) Giampiero Ausili Céfaro et al.   STRAHLENTHERAPIE UND ONKOLOGIE

Identification of Potential Serum Biomarkers of Glioblastoma: Serum Osteopontin Levels Correlate with Poor Prognosis

(2010) P. Sreekanthreddy et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Osteopontin is up-regulated and associated with neutrophil and macrophage infiltration in glioblastoma

(2010) Nadia A. Atai et al.   IMMUNOLOGY

Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target

(2009) Randy L. Jensen   JOURNAL OF NEURO-ONCOLOGY

Osteopontin Expression Correlates with Angiogenesis and Survival in Malignant Astrocytoma

(2009) Koviljka Matusan-Ilijas et al.   PATHOLOGY & ONCOLOGY RESEARCH

Clinical biomarkers for hypoxia targeting

(2008) Quynh-Thu Le et al.   CANCER AND METASTASIS REVIEWS